Browse Twitter Public Accounts with twpublic.com

Twitter eha24 Hashtag Tweets | Twpublic

#EHA24 #EHA2019 Amsterdampic.twitter.com/GTXqkh6WK1 | 23 uur

Tot ziens Amsterdam!!!! #EHA24 #Vondelparkpic.twitter.com/rGfioJgdHm | 23 uur

Hidde Posthuma (⁦⁦@amsterdamumc⁩) over behandel- en overlevingstrends bij nodulaire paragranulomen in Nederland. #NKRdata ⁦@IKNL⁩ #lymsm #EHA24 https://www.oncologie.nu/congresnieuws/behandel-en-overlevingstrends-bij-nodulair-lymfocytenrijk-hl/ … | 23 uur

Presentatie op #EHA24 hematologiecongres in Amsterdam. Overlevingscijfers uit de NL Kankerregistratie #NKRdatahttps://twitter.com/ADinmohamed/status/1139832777698959360 … | 23 uur

Geen voordeel onderhoud met rituximab na R-CHOP bij DLBCL #EHA2019 #EHA24 https://medidact.com/hematologie/geen-voordeel-onderhoud-met-rituximab-na-r-chop-bij-dlbcl/?tid=TIDP310648XD07D9ED0D9764611BD5C339F4B3E8E78YI4 … | 23 uur

Nivolumab bij patiënten met RR Hodgkin-lymfoom #EHA2019 #EHA24 https://medidact.com/hematologie/nivolumab-bij-patienten-met-rr-hodgkin-lymfoom/?tid=TIDP310648XD07D9ED0D9764611BD5C339F4B3E8E78YI4 … | 23 uur

VIDEO: Advances in the treatment and prognosis of TTP w/ Dr Paul Coppo of @HUEstParisien: http://ow.ly/kKVc30pmH5q  @EHA_Hematology #EHA24 #Cancer #Oncology @VJHemOnc | 23 uur

A Phase 3 study of venetoclax or placebo in combination with bortezomib and dexamethasone [Vd +/- VEN] in patients with relapsed/refractory multiple myeloma [RRMM] [Jun 16, 2019] @myelomaMD et al. #EHA24 (=2019) Abstract LB2601 http://ow.ly/xGCu30pmMeP  #mmsm #caxtx #NCT02755597 | 23 uur

“Daratumumab-based combinations have resulted in deep responses and minimal additional toxicity in multiple #myeloma, making such combinations potentially ideal in the treatment of AL #amyloidosis,”–Raymond Comenzo, MD, of @tuftsmedicalctr at #EHA24 https://www.ashclinicalnews.org/on-location/other-meetings/daratumumab-combination-induces-high-response-rates-al-amyloidosis/ … | 23 uur

Jorge E Cortes met with us at #EHA24 to discuss the most important advances in the treatment and management of #AcuteMyeloidLeukaemia and provide an overview of promising emerging therapeutic targets. https://touchoncology.com/media_gallery/jorge-e-cortes-md-eha-2019-advances-in-the-treatment-and-management-of-acute-myeloid-leukaemia/ … @EHA_Hematology | 23 uur

VIDEO: @briankoffman talks about his experience as a Doctor with #CLL w/ @StJudeMedCenter http://ow.ly/XODw30pmFRX  @EHA_Hematology #EHA24 #Leukemia #leusm #Cancer #Oncology | 23 uur

VIDEO: Health technology assessments w/ @ZPWLC of @LeukaemiaCareUK http://ow.ly/8AKA30pmFHg  @VJHemOnc @AcuteLeuk #Leukemia #leusm #Cancer #Oncology #EHA24 @EHA_Hematology | 23 uur

VIDEO: Whole transcriptome RNA sequencing in AML w/ Dr Peter Valk of@ErasmusMC http://ow.ly/JRfK30pmFxi  @VJHemOnc @EHA_Hematology #EHA24 #Leukemia #leusm #Cancer #Oncology | 23 uur

VIDEO: CAR-T in Hematology: Problems and potential w/ Prof @Mohty_EBMT of @HUEstParisien http://ow.ly/rK4r30pl2rV  #EHA24 #CART #Oncology #BloodCancer #Cancer @EHA_Hematology@VJHemOnc | 23 uur

VIDEO: Dasatinib-blinatumomab for ALL w/ Dr Robin Foà of @SapienzaRoma http://ow.ly/cIv530pl2kA  #EHA24 #Leukemia #BloodCancer #leusm #Lymphoma @EHA_Hematology@VJOncology | 23 uur

VIDEO: Mesenchymal stromal cells: Mechanism w/ @DazziFrancesco of @KingsCollegeLon http://ow.ly/7OwO30pl2e4  #EHA24 #Oncology #Cancer @EHA_Hematology @VJHemOnc | 23 uur

Presented by Petra Langerbeins, MD, of @UniCologne at #EHA24: Patients with early-stage chronic lymphocytic #leukemia (#CLL) who received single-agent ibrutinib had longer survival compared with placebohttps://www.ashclinicalnews.org/on-location/single-agent-ibrutinib-improves-survival-prolongs-time-next-treatment-early-stage-cll … | 23 uur

VIDEO: Is there a difference between ALPS disease and ALPS phenotype? w/ Dr Carlo Dufour of Gaslini Children’s Hospital http://ow.ly/Vg5z30pl249  #EHA24 #Autoimmune #Oncology #Cancer @EHA_Hematology@VJHemOnc | 23 uur

VIDEO: Resistance to IMiDs in #MM w/ @OcioEnrique of University Hospital of Salamanca: http://ow.ly/EwE130pjGSG  #EHA24 @EHA_Hematology #MMsm #MultipleMyeloma #Myeloma | 23 uur

Another opportunity to see the video interview from #EHA24 with Professor Theodoros P Vassilakopoulos to discuss the most exciting new developments in standards of care for #HodgkinLymphoma @EHA_Hematologyhttps://touchoncology.com/media_gallery/theodoros-p-vassilakopoulos-md-phd-eha-2019-exciting-new-developments-in-hodgkin-lymphoma/ … | 23 uur